Search

Stella Kim Yi

Examiner (ID: 16227, Phone: (571)270-5123 , Office: P/1742 )

Most Active Art Unit
1742
Art Unit(s)
1791, 1742
Total Applications
1087
Issued Applications
708
Pending Applications
102
Abandoned Applications
311

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17563422 [patent_doc_number] => 20220127571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => CELL POPULATIONS WITH IMPROVED PRODUCTION AND THERAPEUTIC CHARACTERISTICS [patent_app_type] => utility [patent_app_number] => 17/425935 [patent_app_country] => US [patent_app_date] => 2020-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/425935
CELL POPULATIONS WITH IMPROVED PRODUCTION AND THERAPEUTIC CHARACTERISTICS Jan 27, 2020 Abandoned
Array ( [id] => 20356290 [patent_doc_number] => 12472269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => Liver-specific inducible promoters and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/423693 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 22191 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423693 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/423693
Liver-specific inducible promoters and methods of use thereof Jan 19, 2020 Issued
Array ( [id] => 17444076 [patent_doc_number] => 20220064581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => FUNCTIONALIZED SUBSTRATE TO MANIPULATE CELL FUNCTION AND DIFFERENTIATION [patent_app_type] => utility [patent_app_number] => 17/423246 [patent_app_country] => US [patent_app_date] => 2020-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423246 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/423246
FUNCTIONALIZED SUBSTRATE TO MANIPULATE CELL FUNCTION AND DIFFERENTIATION Jan 16, 2020 Pending
Array ( [id] => 17460262 [patent_doc_number] => 20220073567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => ACINETOBACTER BAUMANNII BACTERIOPHAGE MIKAB48 OR LYTIC PROTEIN DERIVED FROM THE BACTERIOPHAGE [patent_app_type] => utility [patent_app_number] => 17/417123 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417123 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/417123
ACINETOBACTER BAUMANNII BACTERIOPHAGE MIKAB48 OR LYTIC PROTEIN DERIVED FROM THE BACTERIOPHAGE Dec 22, 2019 Abandoned
Array ( [id] => 17299873 [patent_doc_number] => 20210395712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => OPTIMIZED GALC GENES AND EXPRESSION CASSETTES AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/416559 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18488 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416559 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/416559
Optimized GALC genes and expression cassettes and their use Dec 19, 2019 Issued
Array ( [id] => 17482640 [patent_doc_number] => 20220090144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS [patent_app_type] => utility [patent_app_number] => 17/417131 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417131 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/417131
Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells Dec 19, 2019 Issued
Array ( [id] => 19609038 [patent_doc_number] => 12157905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => CRISPR gene therapy of fusion gene related cancers [patent_app_type] => utility [patent_app_number] => 17/312808 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/312808
CRISPR gene therapy of fusion gene related cancers Dec 17, 2019 Issued
Array ( [id] => 17355385 [patent_doc_number] => 20220016181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => IMMUNOMODULATORY CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/413314 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -142 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/413314
IMMUNOMODULATORY CELLS AND USES THEREOF Dec 12, 2019 Pending
Array ( [id] => 17428699 [patent_doc_number] => 20220056407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => CELL [patent_app_type] => utility [patent_app_number] => 17/312755 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/312755
CELL Dec 12, 2019 Abandoned
Array ( [id] => 17414300 [patent_doc_number] => 20220049204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => METHODS OF MANUFACTURING CELL BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES [patent_app_type] => utility [patent_app_number] => 17/312783 [patent_app_country] => US [patent_app_date] => 2019-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18445 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/312783
METHODS OF MANUFACTURING CELL BASED PRODUCTS USING SMALL VOLUME PERFUSION PROCESSES Dec 9, 2019 Pending
Array ( [id] => 18141167 [patent_doc_number] => 20230015009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => Methods of Decellularization and Recellularization of Organs and Portions of Organs [patent_app_type] => utility [patent_app_number] => 17/781843 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -57 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781843 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781843
Methods of Decellularization and Recellularization of Organs and Portions of Organs Dec 3, 2019 Pending
Array ( [id] => 19609030 [patent_doc_number] => 12157897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Vectors for protein manufacture [patent_app_type] => utility [patent_app_number] => 17/299542 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 9 [patent_no_of_words] => 14248 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299542 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/299542
Vectors for protein manufacture Dec 3, 2019 Issued
Array ( [id] => 17460600 [patent_doc_number] => 20220073905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => METHODS AND MATERIALS FOR SINGLE CELL TRANSCRIPTOME-BASED DEVELOPMENT OF AAV VECTORS AND PROMOTERS [patent_app_type] => utility [patent_app_number] => 17/416601 [patent_app_country] => US [patent_app_date] => 2019-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416601 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/416601
METHODS AND MATERIALS FOR SINGLE CELL TRANSCRIPTOME-BASED DEVELOPMENT OF AAV VECTORS AND PROMOTERS Dec 3, 2019 Abandoned
Array ( [id] => 18194647 [patent_doc_number] => 20230048166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY [patent_app_type] => utility [patent_app_number] => 17/293797 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293797 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293797
FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY Nov 13, 2019 Pending
Array ( [id] => 19564758 [patent_doc_number] => 12139519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-12 [patent_title] => CRY2 variant having increased photosensitivity and use thereof [patent_app_type] => utility [patent_app_number] => 17/293568 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 6378 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293568 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293568
CRY2 variant having increased photosensitivity and use thereof Nov 12, 2019 Issued
Array ( [id] => 17336421 [patent_doc_number] => 20220002752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => RECOMBINANT VECTORS COMPRISING GENES FOR BINDING DOMAINS AND SECRETABLE PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/292357 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292357 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292357
RECOMBINANT VECTORS COMPRISING GENES FOR BINDING DOMAINS AND SECRETABLE PEPTIDES Nov 12, 2019 Abandoned
Array ( [id] => 17292546 [patent_doc_number] => 20210388385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => SYNP27 (PROB12), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN PROTOPLASMIC ASTROCYTES [patent_app_type] => utility [patent_app_number] => 17/287379 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287379 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/287379
SYNP27 (PROB12), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN PROTOPLASMIC ASTROCYTES Oct 23, 2019 Abandoned
Array ( [id] => 18036525 [patent_doc_number] => 20220380740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => CONSTRUCTS FOR IMPROVED HDR-DEPENDENT GENOMIC EDITING [patent_app_type] => utility [patent_app_number] => 17/288504 [patent_app_country] => US [patent_app_date] => 2019-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288504 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288504
CONSTRUCTS FOR IMPROVED HDR-DEPENDENT GENOMIC EDITING Oct 23, 2019 Pending
Array ( [id] => 17258495 [patent_doc_number] => 20210371480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES [patent_app_type] => utility [patent_app_number] => 17/288311 [patent_app_country] => US [patent_app_date] => 2019-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33968 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -119 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288311 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/288311
COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND OTHER DISEASES Oct 22, 2019 Abandoned
Array ( [id] => 17299891 [patent_doc_number] => 20210395730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants [patent_app_type] => utility [patent_app_number] => 17/284043 [patent_app_country] => US [patent_app_date] => 2019-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284043 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/284043
Selective Curbing of Unwanted RNA Editing (SECURE) DNA Base Editor Variants Oct 9, 2019 Pending
Menu